Cargando…

Clinical Implications of Postoperative Hyperamylasemia after Partial Pancreaticoduodenectomy

INTRODUCTION: The present study aimed to examine the clinical implications of postoperative hyperamylasemia (POH) after partial pancreaticoduodenectomy (PD). METHODS: Data from all consecutive patients undergoing PD were obtained from a prospectively maintained database and reviewed. POH was defined...

Descripción completa

Detalles Bibliográficos
Autores principales: Mintziras, Ioannis, Wächter, Sabine, Manoharan, Jerena, Kanngiesser, Veit, Maurer, Elisabeth, Bartsch, Detlef K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801325/
https://www.ncbi.nlm.nih.gov/pubmed/36589251
http://dx.doi.org/10.1159/000526495
_version_ 1785145825406484480
author Mintziras, Ioannis
Wächter, Sabine
Manoharan, Jerena
Kanngiesser, Veit
Maurer, Elisabeth
Bartsch, Detlef K.
author_facet Mintziras, Ioannis
Wächter, Sabine
Manoharan, Jerena
Kanngiesser, Veit
Maurer, Elisabeth
Bartsch, Detlef K.
author_sort Mintziras, Ioannis
collection PubMed
description INTRODUCTION: The present study aimed to examine the clinical implications of postoperative hyperamylasemia (POH) after partial pancreaticoduodenectomy (PD). METHODS: Data from all consecutive patients undergoing PD were obtained from a prospectively maintained database and reviewed. POH was defined as an elevation of serum pancreatic amylase above the upper limit of normal (53 U/L) on postoperative days 0–2. Clinically relevant POH (cr-POH) was defined as POH in patients with clinically relevant (Clavien-Dindo ≥ III) postoperative complications. RESULTS: POH occurred in 61 of 170 (35.9%) and cr-POH in 24 of 170 (14.1%) patients. Patients with POH had higher rates of clinically relevant postoperative pancreatic fistula (cr-POPF) (44.3 vs. 3.7%, p < 0.001) and clinically relevant postoperative complications than those without POH (39.3 vs. 21.1%, p = 0.001). Patients with cr-POH had higher C-reactive protein (CRP, milligrams per liter) levels on third (257.7 vs. 187.85 mg/L, p = 0.016) and fourth (222.5 vs. 151, p = 0.002) postoperative day (POD) than those with POH alone. Serum procalcitonin (PCT, micrograms per liter) levels on POD 2 (1.2 vs. 0.4 μg/L, p = 0.028) and POD 3 (0.85 vs. 0.4 μg/L, p = 0.001) were also higher in patients with cr-POH. Rates of cr-POPF in patients with cr-POH were higher than in those with POH alone (70.8 vs. 27%, p = 0.001). POH (OR 0.011, 95% CI: 0.001–0.097, p < 0.001) was an independent predictor of cr-POPF in the multivariable analysis. A high-risk pathology, defined as nonadenocarcinoma/nonchronic pancreatitis pathology (OR 0.277, 95% CI: 0.106–0.727, p = 0.009), and a small duct diameter (OR 0.333, 95% CI: 0.139–0.796, p = 0.013) were independent predictors of POH in the multivariable analysis. CONCLUSION: POH is a frequent, but not always clinically relevant, finding after partial PD. Serum CRP and PCT levels in the early postoperative period can be used to identify patients with cr-POH. POH is an independent risk factor for increased postoperative morbidity, including cr-POPF, after partial PD.
format Online
Article
Text
id pubmed-9801325
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-98013252023-12-01 Clinical Implications of Postoperative Hyperamylasemia after Partial Pancreaticoduodenectomy Mintziras, Ioannis Wächter, Sabine Manoharan, Jerena Kanngiesser, Veit Maurer, Elisabeth Bartsch, Detlef K. Visc Med Research Article INTRODUCTION: The present study aimed to examine the clinical implications of postoperative hyperamylasemia (POH) after partial pancreaticoduodenectomy (PD). METHODS: Data from all consecutive patients undergoing PD were obtained from a prospectively maintained database and reviewed. POH was defined as an elevation of serum pancreatic amylase above the upper limit of normal (53 U/L) on postoperative days 0–2. Clinically relevant POH (cr-POH) was defined as POH in patients with clinically relevant (Clavien-Dindo ≥ III) postoperative complications. RESULTS: POH occurred in 61 of 170 (35.9%) and cr-POH in 24 of 170 (14.1%) patients. Patients with POH had higher rates of clinically relevant postoperative pancreatic fistula (cr-POPF) (44.3 vs. 3.7%, p < 0.001) and clinically relevant postoperative complications than those without POH (39.3 vs. 21.1%, p = 0.001). Patients with cr-POH had higher C-reactive protein (CRP, milligrams per liter) levels on third (257.7 vs. 187.85 mg/L, p = 0.016) and fourth (222.5 vs. 151, p = 0.002) postoperative day (POD) than those with POH alone. Serum procalcitonin (PCT, micrograms per liter) levels on POD 2 (1.2 vs. 0.4 μg/L, p = 0.028) and POD 3 (0.85 vs. 0.4 μg/L, p = 0.001) were also higher in patients with cr-POH. Rates of cr-POPF in patients with cr-POH were higher than in those with POH alone (70.8 vs. 27%, p = 0.001). POH (OR 0.011, 95% CI: 0.001–0.097, p < 0.001) was an independent predictor of cr-POPF in the multivariable analysis. A high-risk pathology, defined as nonadenocarcinoma/nonchronic pancreatitis pathology (OR 0.277, 95% CI: 0.106–0.727, p = 0.009), and a small duct diameter (OR 0.333, 95% CI: 0.139–0.796, p = 0.013) were independent predictors of POH in the multivariable analysis. CONCLUSION: POH is a frequent, but not always clinically relevant, finding after partial PD. Serum CRP and PCT levels in the early postoperative period can be used to identify patients with cr-POH. POH is an independent risk factor for increased postoperative morbidity, including cr-POPF, after partial PD. S. Karger AG 2022-12 2022-10-24 /pmc/articles/PMC9801325/ /pubmed/36589251 http://dx.doi.org/10.1159/000526495 Text en Copyright © 2022 by The Author(s). Published by S. Karger AG, Basel https://creativecommons.org/licenses/by/4.0/This article is licensed under the Creative Commons Attribution 4.0 International License (CC BY). Usage, derivative works and distribution are permitted provided that proper credit is given to the author and the original publisher.
spellingShingle Research Article
Mintziras, Ioannis
Wächter, Sabine
Manoharan, Jerena
Kanngiesser, Veit
Maurer, Elisabeth
Bartsch, Detlef K.
Clinical Implications of Postoperative Hyperamylasemia after Partial Pancreaticoduodenectomy
title Clinical Implications of Postoperative Hyperamylasemia after Partial Pancreaticoduodenectomy
title_full Clinical Implications of Postoperative Hyperamylasemia after Partial Pancreaticoduodenectomy
title_fullStr Clinical Implications of Postoperative Hyperamylasemia after Partial Pancreaticoduodenectomy
title_full_unstemmed Clinical Implications of Postoperative Hyperamylasemia after Partial Pancreaticoduodenectomy
title_short Clinical Implications of Postoperative Hyperamylasemia after Partial Pancreaticoduodenectomy
title_sort clinical implications of postoperative hyperamylasemia after partial pancreaticoduodenectomy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801325/
https://www.ncbi.nlm.nih.gov/pubmed/36589251
http://dx.doi.org/10.1159/000526495
work_keys_str_mv AT mintzirasioannis clinicalimplicationsofpostoperativehyperamylasemiaafterpartialpancreaticoduodenectomy
AT wachtersabine clinicalimplicationsofpostoperativehyperamylasemiaafterpartialpancreaticoduodenectomy
AT manoharanjerena clinicalimplicationsofpostoperativehyperamylasemiaafterpartialpancreaticoduodenectomy
AT kanngiesserveit clinicalimplicationsofpostoperativehyperamylasemiaafterpartialpancreaticoduodenectomy
AT maurerelisabeth clinicalimplicationsofpostoperativehyperamylasemiaafterpartialpancreaticoduodenectomy
AT bartschdetlefk clinicalimplicationsofpostoperativehyperamylasemiaafterpartialpancreaticoduodenectomy